ENTITY

Telomir Pharmaceuticals (TELO US)

Analysis

Health Care • United States

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of telomir 1, a novel treatment that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer. Telomir Pharmaceuticals serves customers in the United States.

Refresh

No events found

We’ll display events we find for Telomir Pharmaceuticals here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00